Article
Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin - 20 Jan 2011
Hurt A C, Deng Y M, Ernest J, Caldwell N, Leang L, Iannello P, Komadina N, Shaw R, Smith D, Dwyer D E, Tramontana A R, Lin R T, Freeman K, Kelso A, Barr I G
Abstract excerpt
During the first year of the influenza A(H1N1) 2009 pandemic, unprecedented amounts of the neuraminidase inhibitors, predominantly oseltamivir, were used in economically developed countries for the treatment and prophylaxis of patients prior to the availability of a pandemic vaccine. Due to concerns about the development of resistance, over 1,400 influenza A(H1N1) 2009 viruses isolated from the Asia-Pacific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.